Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
0.4500
+0.0295 (7.02%)
At close: Feb 23, 2026
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $867.55 thousand as of February 24, 2026.
Market Cap
867.55K
Enterprise Value
2.14M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.45
Market Cap Chart
Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from 9.64M to 867.55K, a decrease of -91.00%. That is a compound annual growth rate of -95.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 867.55K | -65.51% |
| Dec 31, 2025 | 2.52M | -73.91% |
| May 19, 2025 | 9.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evofem Biosciences | 1.19M |
| CERo Therapeutics Holdings | 1.18M |
| International Stem Cell | 1.16M |
| Halberd | 1.08M |
| Eastgate Biotech | 1.06M |
| Emmaus Life Sciences | 982.64K |
| Avenue Therapeutics | 922.50K |
| EV Biologics | 840.53K |